High Quality Quinine Dihydrochloride Injection for Severe Malaria Treatment

Product Details
Customization: Available
Application: Injection
Usage Mode: Injection
Still deciding? Get samples of $ !
Request Sample

360° Virtual Tour

Diamond Member Since 2025

Suppliers with verified business licenses

Audited Supplier Audited Supplier

Audited by an independent third-party inspection agency

High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
Years of Export Experience
The export experience of the supplier is more than 10 years
Exhibition Experience
The supplier had participated in offline trade shows, you can check the Audit Report for more information
Experienced Team
The supplier has 18 foreign trading staff(s) and 6 staff(s) with over 6 years of overseas trading experience
to see all verified strength labels (26)
  • High Quality Quinine Dihydrochloride Injection for Severe Malaria Treatment
  • High Quality Quinine Dihydrochloride Injection for Severe Malaria Treatment
  • High Quality Quinine Dihydrochloride Injection for Severe Malaria Treatment
  • High Quality Quinine Dihydrochloride Injection for Severe Malaria Treatment
  • High Quality Quinine Dihydrochloride Injection for Severe Malaria Treatment
  • High Quality Quinine Dihydrochloride Injection for Severe Malaria Treatment
Find Similar Products

Basic Info.

Model NO.
AMC14021-06
Suitable for
Elderly, Children, Adult
State
Liquid
Shape
Liquid
Type
Biological Products
Pharmaceutical Technology
Chemical Synthesis
Standard Available
Bp, Cp
Function
Antimalarial
Delivery Time
30~60 Days
OEM/ODM
Support
Transport Package
Box
Specification
400MG/2ML, 10Ampoules
Trademark
Shinepharm, OEM
Origin
China
HS Code
3004490010
Production Capacity
1000000 Boxes/Month

Product Description


High Quality Quinine Dihydrochloride Injection for Severe Malaria Treatment

QUININE DIHYDROCHLORIDE INJECTION 

Indications

For the treatment of acute attacks of malaria, including attacks due to chloroquine-resistant or multi-drug-resistant strains of Plasmodium falciparum. Quinine is used Parenterally for cerebral, severe or complicated malaria, or when vomiting prevents retention of an orally administered drug. Quinine dihydrochloride is the salt usually employed for the preparation of injections.

Dosage and Administration

Usage:

1.By Slow Iv Infusion or deep IM Injection:The solution should be diluted before administration infused slowly over 4 hours. Hypotension and cardiac arrest may result from rapid intravenous injection. Intravenous quinine should be given only by infusion.If IV infusion is not possible, quinine dihydrochloride has been given IM route. The IM route should only be used as a last resort.

2.Adult Dosage: Usual adult and adolescent dose Malaria, Plasmodium falciparum, severe (treatment): Loading dose: 20 mg/kg up to a maximum of 1400 mg given slowly by infusion over 4 hours.

Precautions & Warning:

1.Quinine must be used with caution in patients with atrial fibrillation or other serious heart disease.

2.Quinine may aggravate symptoms of myasthenia gravis and should be used with care if at all in such patients.

3.Quinine may cause Hypoprothrombinaemia and enhance the effects of anticoagulants.

4Antimalarial agents and especially quinine, when given for prolonged periods, have been implicated in precipitating black water fever.

5.Precautions Check for hypersensitivity to quinine or quinidine before administration. It is important that when given intravenously it should be given by slow infusion and the patient observed closely for signs of cardiotoxicity.

6.Pulse and blood pressure should be closely monitored

7.Haemolysis

8.Atrial Fibrillation

Contraindications:

1.Hypersensitivity to quinine or quinidine

2.Hypoglycemia (quinine stimulates release of Pancreatic hormone from the pancreas; hypoglycemia may also be a complication of severe P. falciparum malaria, especially in children and during pregnancy)

3.Myasthenia gravis (quinine may exacerbate muscle weakness in myasthenia gravis due to its neuromuscular blocking effects) Purpura, thrombocytopenic, or history of (quinine may cause thrombocytopenic purpura, especially in highly sensitive patients or in patients with a previous history of this reaction to quinine)

Quinine Dihydrochloride Intravenous Infusion is contraindicated for use in premature infants because the formulation contains benzylalcohol.

Adverse Reactions:

1.Very common (≥10%) Gastrointestinal disturbances (abdominal or stomach cramps or pain; diarrhea; nausea; vomiting).

2.Common (1%-10%) cinchonism occurs. Cinchonism symptoms include tinnitus, impaired hearing, headache, nausea, disturbed vision, vomiting, abdominal pain, diarrhoea, and vertigo. Blood dyscrasias such as agranulocytosis, leukopenia, and/or thrombocytopenia hypoglycemia

3.Serious ADR (<1%) hypersensitivity reactions hypoprothrombinemia

Drug interactions:

1.Digitalis glycosides: Quinine markedly reduces the renal clearance of digoxin and digoxin levels may be doubled.

2.Flecainide: Quinine reduces the systemic clearance.

3.Warfarin: Quinine may potentiate warfarin by inhibiting its hepatic metabolism. 4.Cimetidine: Cimetidine inhibits the hepatic metabolism of quinine. Hypoglycaemic drugs: As quinine stimulates the release of Pancreatic hormone from islet cells, diabetic control may be compromised.

5.Mefloquine

Storage instructions:

Do not Store above 30 ºC. Protect from light. keep out of reach of children.

 
High Quality Quinine Dihydrochloride Injection for Severe Malaria TreatmentHigh Quality Quinine Dihydrochloride Injection for Severe Malaria Treatment

High Quality Quinine Dihydrochloride Injection for Severe Malaria Treatment

 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier